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Real-time baseline coagulation
profiles using ROTEM in patients
undergoing liver transplantation
Paul DelPrato, Uzung Yoon, MD*

Introduction & Objectives
• Rotational thromboelastometry (ROTEM)
is a real-time monitoring system of
whole blood hemostasis
• Measurements acquired can be
considered superior to lab-based tests
such as aPTT and PT/INR (Theusinger, et
al. 2013)
• Long-term objective is to increase
utilization of ROTEM in complex surgical
procedures
– Currently used at Jefferson in liver-transplant
procedures

Source: Instrumentation Laboratory

Source: Williams (2016)

Research Question
& Hypothesis
• Research Question

– In liver transplant patients, what are
baseline coagulation profiles – using
basic ROTEM measurements – to
expect based on certain transplant
procedure etiologies?

• Hypothesis

– More coagulopathy – increased
ROTEM clotting time, etc. – will be
observed in patients with whole liver
transplant etiologies (e.g. alcoholic
cirrhosis) than a focal hepatocellular
carcinoma transplant etiology

Brief review of methods
Data: ROTEM coagulation measurements at Jefferson have been acquired
from approximately 400 liver transplant patients since 2013
PICO

Population - liver transplant patients at Jefferson, 2013-present
Intervention - ROTEM data acquired during transplant procedure
Comparator - patient groups based on hepatocellular carcinoma vs.
whole hepatocellular pathology etiology
Other –
–

–

Outcome measures (complete data in 221 patients) –
•

ROTEM coagulation measurements e.g. clotting time, clot formation time

•

MELD scores (uses serum bilirubin, INR, serum creatinine from EPIC)

Analysis – paired t-test comparing patient groups, correlations run
comparing continuous measurement variables

Prior to reporting coagulation profiles of patients
from our database, we wanted to test levels of
correspondence between our ROTEM
measurements with a proven indicator of risk…

MELD scores in liver transplants
• MELD score – Model for Endstage Liver Disease -- is
predictive of post-surgery
mortality
• Computed from EPIC chart
review of patients in database
using labs immediately prior to
surgery:
1.
2.
3.

•

Serum creatinine
INR
Serum bilirubin

These values will be included
in patient coagulation profiles

Figure 1 of Saab et al. (2003),
Liver transplantation. 1 year
Cox survival estimate.

Exploratory population-level
analysis
• Question: Do patient MELD scores correlate
with baseline ROTEM clotting times?

Results, HCC vs. non-HCC
Group

N

Clotting Time
(Mean)

Clotting Time
(StDev)

MELD
(mean)

MELD
(StDev)

HCC

75

813.6

507.4

12.8

6.1

Other

146

944.0

495.4

23.7

9.8

For both ROTEM CT scores and MELD scores,
the non-cancer patient group had values
trending in the direction suggesting more
coagulopathy
Large levels of variance are present in these
variables

Obstacles
• Data retention:

– 400 patients in total database
– 283 have a baseline NATEM measurement (71%)
– 221 have baseline NATEM + MELD score (55% of grand
total)

• Our initial hypothesis comparison groups –
hepatocellular carcinoma (N=87)* vs. non-cancer
(N=134)* – suffer from unbalanced sample sizes
* - Distinct patients with baseline natem values and adjusted MELD scores

Conclusions
• From this project:

– Further analysis is needed to
investigate coagulopathy measures in
HCC compared to other transplants

• Overall, our overarching aim is to
provide more resources for ROTEM
users to increase overall utilization
in ORs
• Providing baseline profiles for liver
transplant patients has utility even
without hypothesis testing

Future directions
• Outlier handling to reduce population
variance
– Is this methodologically sound while studying
liver pathology?

• Assess coagulation measures across other
demographic variables
– Age, Sex, Race/Ethnicity, other disease processes
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